REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $476,831 | -43.4% | 41,572 | +24.8% | 0.00% | – |
| Q2 2023 | $843,127 | -17.4% | 33,312 | +5.2% | 0.00% | -100.0% |
| Q1 2023 | $1,020,316 | +80.6% | 31,677 | +3.5% | 0.00% | – |
| Q4 2022 | $564,839 | -23.8% | 30,598 | +11.5% | 0.00% | -100.0% |
| Q3 2022 | $740,799 | +91.9% | 27,437 | -1.8% | 0.00% | – |
| Q2 2022 | $385,993 | -31.9% | 27,930 | -3.9% | 0.00% | – |
| Q1 2022 | $566,729 | -6.0% | 29,063 | -21.4% | 0.00% | – |
| Q4 2021 | $603,000 | -40.6% | 36,979 | +1.4% | 0.00% | -100.0% |
| Q3 2021 | $1,016,000 | -13.2% | 36,468 | -7.6% | 0.00% | 0.0% |
| Q2 2021 | $1,170,000 | +16.9% | 39,475 | +10.3% | 0.00% | 0.0% |
| Q1 2021 | $1,001,000 | -6.6% | 35,804 | -5.4% | 0.00% | 0.0% |
| Q4 2020 | $1,072,000 | +19.9% | 37,833 | +6.4% | 0.00% | 0.0% |
| Q3 2020 | $894,000 | +3.7% | 35,558 | +5.5% | 0.00% | 0.0% |
| Q2 2020 | $862,000 | +87.0% | 33,706 | +8.3% | 0.00% | 0.0% |
| Q1 2020 | $461,000 | +6.5% | 31,123 | +16.7% | 0.00% | – |
| Q4 2019 | $433,000 | +11.3% | 26,660 | -5.6% | 0.00% | – |
| Q3 2019 | $389,000 | +6.0% | 28,245 | -0.1% | 0.00% | – |
| Q2 2019 | $367,000 | -8.9% | 28,268 | +10.5% | 0.00% | – |
| Q1 2019 | $403,000 | -3.4% | 25,577 | +23.6% | 0.00% | -100.0% |
| Q4 2018 | $417,000 | -24.5% | 20,698 | -6.7% | 0.00% | 0.0% |
| Q3 2018 | $552,000 | -18.8% | 22,191 | -10.4% | 0.00% | 0.0% |
| Q2 2018 | $680,000 | +7.9% | 24,769 | +21.1% | 0.00% | 0.0% |
| Q1 2018 | $630,000 | -3.1% | 20,446 | +12.5% | 0.00% | 0.0% |
| Q4 2017 | $650,000 | +31.3% | 18,172 | +1.3% | 0.00% | 0.0% |
| Q3 2017 | $495,000 | +2.5% | 17,938 | -2.0% | 0.00% | 0.0% |
| Q2 2017 | $483,000 | +36.4% | 18,304 | +7.5% | 0.00% | – |
| Q1 2017 | $354,000 | +13.8% | 17,029 | +13.5% | 0.00% | – |
| Q4 2016 | $311,000 | +30.7% | 15,008 | +2.3% | 0.00% | – |
| Q3 2016 | $238,000 | +17.2% | 14,668 | -1.7% | 0.00% | – |
| Q2 2016 | $203,000 | -6.9% | 14,920 | +20.1% | 0.00% | – |
| Q1 2016 | $218,000 | -40.4% | 12,420 | +15.7% | 0.00% | – |
| Q4 2015 | $366,000 | +16.9% | 10,732 | +2.0% | 0.00% | – |
| Q3 2015 | $313,000 | -5.7% | 10,522 | +1.3% | 0.00% | – |
| Q2 2015 | $332,000 | +137.1% | 10,382 | +54.7% | 0.00% | – |
| Q1 2015 | $140,000 | +26.1% | 6,711 | +2.5% | 0.00% | – |
| Q4 2014 | $111,000 | +1.8% | 6,548 | +16.0% | 0.00% | – |
| Q3 2014 | $109,000 | -27.8% | 5,646 | +27.0% | 0.00% | – |
| Q2 2014 | $151,000 | – | 4,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |